In Meril v. Edwards, the Court of Appeal (CoA) of the (European) Unified Patent Court held that permanent injunctions can be withheld when interests of patients are taken into account
In a November 25, 2025 decision in the case of
SCCR 47: Statement by Knowledge Ecology International on copyright limitations and exceptions
On Tuesday afternoon, 2 December 2025, Knowledge Ecology International made the following statement on copyright limitations and exceptions at the 47th session of the WIPO Standing Committee on Copyright and Related Rights. I wanted to comment first on the African… Continue Reading
IGWG 4 – KEI statement on the 2025 European Health Data Spaces Regulation
On Monday, 1 December 2025, Knowledge Ecology International (KEI) delivered the following statement on the 2025 European Health Data Spaces Regulation during the afternoon ession with Relevant Stakeholders which took place at WHO headquarters in Geneva from 16:45–17.15 CET. IGWG… Continue Reading
KEI Comments on Exclusive License to Stage One Immunotherapeutics
On October 20, 2025, Knowledge Ecology International (KEI) submitted comments to the NIH in response to the Federal Register notice titled, “Prospective Grant of an Exclusive Patent License: Substituted Quinoline Analogs As Aldehyde Dehydrogenase 1A1 Inhibitors” (90 FR 47782) The… Continue Reading
KEI Comments on Exclusive License of Zika Strain to AARI
On October 14, 2025, Knowledge Ecology International (KEI) provided the NIH with comments regarding the “Prospective Grant of Exclusive License, Inter-Institutional Agreement-Institution Lead: Development of Zika Virus Strains for Use in Oncolytic Therapy” (90 FR 46414) to Advocate Aurora Research… Continue Reading
KEI Comments to the NIH on Exclusive License to Lysin Therapeutics
On September 24, 2025, Knowledge Ecology International submitted comments to the NIH regarding the “Prospective Grant of an NCI Exclusive Patent License: Use of Anti-Mesothelin Immunotoxins for the Treatment of Mesothelin-Expressing Cancers” (90 FR 43617) to Lysin Therapeutics. Although the… Continue Reading
WHO IGWG3 – KEI’s statement at opening, focuses on transparency, technology transfer and pricing of products, WHO pathogen access and benefit sharing system (PABS) negotiations
On Monday, 3 November 2025, Knowledge Ecology International (KEI) delivered the following intervention at the Third meeting of the open-ended Intergovernmental Working Group on the WHO Pandemic Agreement. Given the significant attacks on the WHO and the importance of restoring… Continue Reading
KEI Briefing Note, 2024-9, Voting rights in treaties.
Voting rights in treaties KEI Briefing Note 2024-9 November 27, 2024 Arianna Schouten, Thiru Balasubramaniam and James Love In 2024, several treaties were concluded or were being negotiated. Among the many issues debated were the articles and governance, including the… Continue Reading
Delhi High Court Rejects Roche’s Appeal, Paving Way for Affordable Generic Risdiplam
Below is a short note on good news on a court case in India concerning access to risdiplam, a treatment for spinal muscular atrophy (SMA). The note is followed by a statement on the case by Third World Network (TWN),… Continue Reading
PABS Annex: WHO Member States to Allow Observers as Negotiations Enter Critical Phase
At around 6:30 PM CEST on Friday, 19 September 2025, relevant stakeholders were invited to observe the closure of the second meeting of the open-ended Intergovernmental Working Group on the WHO Pandemic Agreement and witnessed WHO Member States set an… Continue Reading